FindTrial
Sign In

To evaluate the safety and efficacy of Makhana powder(Unani compound formulation) in Oligospermia on scientific parameters.

Efficacy of Sufoof Makhana in the Management of Qillate Haiwan-e-Manwiya (Oligospermia) A Single Blind Randomized Placebo Controlled Trial. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/106634
Enrollment
60
Registered
2026-03-20
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N461- Oligospermia

Interventions

Intervention1: Sufoof Makhana: In test group 6gm powder of , Tukhme Talmakhana (Asteracantha longifolia), Elaichi khurd(Eletteria cardamomum borivilianum), Salab misri (Orchis latifolia) and Satawar

Sponsors

Department of Moalajat Ajmal Khan Tibbiya College and Hospital Aligarh Muslim University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients in the age group of 21 to 50 years Patients having sperm count more than 5 millions and less than 15 millions per mL Patients having total sperm motility more than 15 percents and less than 40 percents Those who give written consent Patient underwent at least 2 weeks washout period before randomization

Exclusion criteria

Exclusion criteria: Patients having Azoospermia on laboratory diagnosis Patients of known case of genetic abnormality like Klinefilter s Syndrome Patients diagnosed with any Uro-genital infection Patients diagnosed from structural anomalies like Hydrocele Varicocele Carcinoma of testis Undescended testis Epispadias Hypospadias Patients having history of trauma like Urethral injury/genital injury acquired blockage in vas deference and epididymis(infection/surgical), Retrograde ejaculation, Testicular Torsion, Trauma and Malignancy Patient with history of systemic disorders like Diabetes mellitus, Hypertension Renal disease, Liver disease, and Cardiac disease Patient having history of any STDs, HIV and Hepatitis B infections Patient having past history of mumps

Design outcomes

Primary

MeasureTime frame
Primary outcome: The primary outcome of the study is to evaluate the efficacy of Sufoof Makhana in patients suffering from oligospermia by assessing changes in total sperm count. Timepoint: Follow Up: on 15th , 30th and 60th days—

Secondary

MeasureTime frame
The secondary outcomes is to evaluate efficacy of Sufoof Makhana in patients suffering from oligospermia by assessing changes in sperm motility and sperm morphology.Timepoint: Follow Up: on 15th, 30th and 60th days—

Countries

India

Contacts

Public ContactFawaz Nasir

Ajmal Khan Tibbiya College and Hospital, Aligarh Muslim University

drbdkhanamu@gmail.com9412333174

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026